Carboprost tromethamine

Generic Name
Carboprost tromethamine
Brand Names
Hemabate
Drug Type
Small Molecule
Chemical Formula
C25H47NO8
CAS Number
58551-69-2
Unique Ingredient Identifier
U4526F86FJ
Background

A nonsteroidal abortifacient agent that is effective in both the first and second trimesters of pregnancy.

Indication

For aborting pregnancy between the 13th and 20th weeks of gestation as calculated from the first day of the last normal menstrual period and in the following conditions related to second trimester abortion: 1. Failure of expulsion of the fetus during the course of treatment by another method; 2. Premature rupture of membranes in intrauterine methods with los...

Associated Conditions
Unresponsive Postpartum Haemorrhage (PPH) caused by Uterine Atony
Associated Therapies
Pregnancy termination therapy
Clinical Trials
Related News

Comparing the Dose-response Profiles of Uterotonics After Initial Carbetocin Administration - an Ex-vivo Study in Desensitized Human Myometrium

First Posted Date
2024-02-29
Last Posted Date
2024-04-12
Lead Sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Target Recruit Count
32
Registration Number
NCT06285409
Locations
🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

Carboprost (Hemabate) for Fibroid Resection

First Posted Date
2022-08-29
Last Posted Date
2023-11-07
Lead Sponsor
Northwestern University
Target Recruit Count
30
Registration Number
NCT05518812
Locations
🇺🇸

Northwestern University - Northwestern Medicine, Lavin Family Pavilion, Chicago, Illinois, United States

Early Usage of Bakri Ballon in Managing Postpartum Hemorrhage

First Posted Date
2016-08-10
Last Posted Date
2016-12-16
Lead Sponsor
Dongyu Wang
Target Recruit Count
472
Registration Number
NCT02861482
Locations
🇨🇳

Obstetrics and Gynechology Department of the 1st affiliated hospital of Sun Yat-sen University, Guangzhou, Guangdong, China

Comparison of IV Ergonovine With IM Carboprost, With Oxytocin IV, During Cesarean Section for Failure to Progress

Not Applicable
Completed
Conditions
Postpartum Hemorrhage
Interventions
Drug: Oxytocin
Drug: Ergot
Drug: Carboprost
First Posted Date
2013-06-05
Last Posted Date
2020-09-24
Lead Sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Target Recruit Count
105
Registration Number
NCT01869556
Locations
🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

Impact of Uterotonic Agents on Isolated Human Myometrium

First Posted Date
2009-10-02
Last Posted Date
2014-02-20
Lead Sponsor
Samuel Lunenfeld Research Institute, Mount Sinai Hospital
Target Recruit Count
56
Registration Number
NCT00989027
Locations
🇨🇦

Mount Sinai Hospital, Toronto, Ontario, Canada

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy